161 related articles for article (PubMed ID: 22454412)
1. Funding oncology clinical trials: are cooperative group trials sustainable?
Seow HY; Whelan P; Levine MN; Cowan K; Lysakowski B; Kowaleski B; Snider A; Xu RY; Arnold A
J Clin Oncol; 2012 May; 30(13):1456-61. PubMed ID: 22454412
[TBL] [Abstract][Full Text] [Related]
2. Robbing peter to pay paul: financing clinical trial follow-up.
Dilts DM
J Clin Oncol; 2012 May; 30(13):1404-5. PubMed ID: 22454422
[No Abstract] [Full Text] [Related]
3. Estimating per patient funding for cancer clinical trials: an Ontario based survey.
Wright JR; Roche K; Smuck B; Cormier J; Cecchetto S; Akow M; Pilatzke S; Pritchard KI
Contemp Clin Trials; 2005 Aug; 26(4):421-9. PubMed ID: 15925548
[TBL] [Abstract][Full Text] [Related]
4. Funding patient-reported outcomes in cancer clinical trials.
Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
[TBL] [Abstract][Full Text] [Related]
5. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
6. Adapting clinical trials networks to promote cancer prevention and control research.
Weiner BJ; McKinney MM; Carpenter WR
Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
[TBL] [Abstract][Full Text] [Related]
7. Costs of quality-of-life research in Southwest Oncology Group trials.
Moinpour CM
J Natl Cancer Inst Monogr; 1996; (20):11-6. PubMed ID: 8750461
[TBL] [Abstract][Full Text] [Related]
8. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
Tobisu K
Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
[TBL] [Abstract][Full Text] [Related]
9. Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.
Wang-Gillam A; Williams K; Novello S; Gao F; Scagliotti GV; Govindan R
J Clin Oncol; 2010 Aug; 28(24):3803-7. PubMed ID: 20644091
[TBL] [Abstract][Full Text] [Related]
10. Using patients as their own controls for cost evaluation of phase I clinical trials.
Sherman EJ; Rubin DM; Venkatraman E; Schwartz GK; Miller VA; Radzyner MH; Ruchlin HS; Spriggs D; Pfister DG
J Clin Oncol; 2004 Apr; 22(7):1308-14. PubMed ID: 15051779
[TBL] [Abstract][Full Text] [Related]
11. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
12. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trials: A Congressional Focus of Need.
Coltman CA
Oncologist; 1997; 2(4):VII-VIII. PubMed ID: 10388059
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
Huber SL
Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials in the academic cancer center.
J Natl Compr Canc Netw; 2011 Nov; 9(11):lii. PubMed ID: 22056659
[No Abstract] [Full Text] [Related]
16. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB
J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312
[TBL] [Abstract][Full Text] [Related]
17. Networking may be key to academic cancer center survival under managed care.
Oncology (Williston Park); 1995 Nov; 9(11):1127, 1133. PubMed ID: 8703678
[No Abstract] [Full Text] [Related]
18. Drug cost avoidance resulting from cancer clinical trials.
Bredin C; Eliasziw M; Syme R
Contemp Clin Trials; 2010 Nov; 31(6):524-9. PubMed ID: 20840876
[TBL] [Abstract][Full Text] [Related]
19. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting.
Hall MA; Friedman JY; King NM; Weinfurt KP; Schulman KA; Sugarman J
Acad Med; 2010 Oct; 85(10):1554-6. PubMed ID: 20881671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
